Pierre Sargis Sayad, the Chief Medical Officer of $FENC, sold 12,000 shares of the company on 08-31-2026 for an estimated $146,160. We received data on the trade from a recent SEC filing. This was a sale of approximately 55.8% of their shares of this class of stock. Following this trade, they now own 9,519 shares of this class of $FENC stock.
$FENC Insider Trading Activity
$FENC insiders have traded $FENC stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $FENC stock by insiders over the last 6 months:
- ROBERT ANDRADE (CHIEF FINANCIAL OFFICER) sold 75,000 shares for an estimated $883,500
- PIERRE SARGIS SAYAD (Chief Medical Officer) sold 12,000 shares for an estimated $146,160
- ROSTY RAYKOV sold 10,781 shares for an estimated $69,753
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$FENC Hedge Fund Activity
We have seen 70 institutional investors add shares of $FENC stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOUTHPOINT CAPITAL ADVISORS LP removed 2,744,741 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $29,505,965
- SOLAS CAPITAL MANAGEMENT, LLC removed 592,832 shares (-23.9%) from their portfolio in Q2 2026, for an estimated $6,372,944
- AIGH CAPITAL MANAGEMENT LLC added 504,537 shares (+25.5%) to their portfolio in Q2 2026, for an estimated $5,423,772
- PROSPECT CAPITAL ADVISORS, LLC added 497,800 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,351,350
- AWM INVESTMENT COMPANY, INC. added 440,161 shares (+61.1%) to their portfolio in Q2 2026, for an estimated $4,731,730
- BLACKROCK, INC. added 358,893 shares (+26.2%) to their portfolio in Q2 2026, for an estimated $3,858,099
- ROSALIND ADVISORS, INC. added 279,800 shares (+9.6%) to their portfolio in Q2 2026, for an estimated $3,007,850
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$FENC Price Targets
Multiple analysts have issued price targets for $FENC recently. We have seen 2 analysts offer price targets for $FENC in the last 6 months, with a median target of $14.5.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $16.0 on 05/22/2026
- David Nierengarten from Wedbush set a target price of $13.0 on 04/16/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
